Back

Different risk of new-onset atrial fibrillation on patients with primary aldosteronism after surgical or medical treatment: a nationwide longitudinal cohort-based study

19 March 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Chien-Ting Pan

National Taiwan University Hospital, Taipei (Taiwan)

8 More presentations in this session

Presentation thumbnail
Associate Professor J. Park (Seoul, KR)
Abstract Slides
Presentation thumbnail
Associate Professor J. Park (Seoul, KR)
Abstract Slides
Presentation thumbnail
Doctor T. Seewoester (Leipzig, DE)
Abstract
Presentation thumbnail
Doctor P. Amador (Setubal, PT)
Abstract Slides
Presentation thumbnail
Associate Professor Y. Baek (Incheon, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

The Event

Event poster

EHRA 2019

19 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Primary aldosteronism and aldosterone-driven hypertension
29 August 2025
thumbnail
Congress Presentation
Different risk of atrial fibrillation according to the type of cancer: a nationwide population-based study
28 August 2020
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
New-onset atrial fibrillation in the ICU: a temporary disturbance or a lasting burden?
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources